SCMS Summer Membership Cruise

Message from the President
On August 28, 2016, the Snohomish County Medical Society Board of Trustees would like to invite you to a summer cruise.  We thank you for your support of your local medical community and appreciate your membership.

This is a social event sponsored by the SCMS. We will be on the Argosy Sightseer and provide a buffet lunch and beverages. Family members and guests are welcome. Please include them in your RSVP.

Please RSVP by August 15, 2016. This is open to the first 50 SCMS members who RSVP.  Please save this date and join us for a 3 hour cruise departing from the Edmonds pier. 1:00 pm to 4:00 pm. Boarding begins at 12:30 pm.  Once you RSVP and are confirmed, details for the cruise will be emailed to you.

Please RSVP the total number in your party and the number of children. Email your RSVP to: LMK@wsma.org

Thank you and we look forward to seeing you this summer.

Jerry Yorioka, MD
SCMS President

Facebooktwittermail

SCMS Looks to Establish a Dialogue Forum

The Board would like to establish a forum for dialogue between the general public (patients) and organized medicine (physicians).  One suggested topic is “Does Everyone Need a Primary Care Physician?”   (Another is “The Threat of Human Trafficking in our Community”)   A recent presentation by Fire District 7 emphasized the importance to emergency services of having a known primary care provider.  If you have any thoughts on topics or how to plan a successful “public forum”  before the end of the year, please contact the SCMS office at: LMK@wsma.org or call: 206-956-3624

Facebooktwittermail

Sea Mar Family Medicine Residency is ACCREDITED!

The ACGME has accredited the application for the first residency in Snohomish county- the Sea Mar Marysville Community Health Center Family Medicine Residency. It will start July 2017, with 6 Family Medicine residents. By the 3rd year, we will have 18 residents in the program.

A big thank you to Providence Hospital for their strong support from the start. Also, thank you to all the physicians in our community that have supported us, the response has been incredible. It will be great to have residents training here, and typically a significant number will stay in the community for their careers.

A little background- we are responding to the local (and national) need for more family medicine physicians. Sea Mar is the institutional sponsor, which is a newer model for residency training. This model has the clinic control the training priorities, as the clinic is where the physician will spend most of their career. The hospital is also important in training the residents, as the expectation is that our graduates will practice full spectrum family medicine. We are looking for residents that want to work in an underserved or rural practice setting. They will have the training to be pluripotent, practicing to the needs of the community they work in.

Currently we are developing the curriculum for each first year rotation. These are mainly inpatient rotations (IM,OB,surgery,ICU, NICU) as well as some outpatient (community medicine, peds, ortho,derm). Our faculty and “champions” at the hospital and in the specialty clinics are working together, discussing structure, goals and objectives for each rotation. There are also 6 weeks of elective time the first year, so we are looking at interesting rotation ideas for that time. We have good resources for attendings to access, regarding teaching tips, working with residents, staying on time, doing evaluations, etc. We are doing monthly faculty development sessions for our core faculty. I recently finished the University of Washington Family Medicine Faculty Development Fellowship. Prior to that, I did an AAFP NIPDD Family Residency Program Director Fellowship. I am using this training to help prepare faculty and attendings for their residency roles. We want everyone working with the residents to be supported and knowledgeable when they work with the residents. We will have a Sharepoint with information on the residents, and teaching/evaluating resources.

We will continue to work with UW medical students, and welcome the WSU medical students to Everett. It is exciting to see the area expanding in academic medicine. It is good to pay back and contribute to educating physicians that care for the next generation in our community. Please let me know if you are interested in teaching residents, we would love to talk to you!

Residency link:  http://seamarmarysvilleresidency.org/

Greg Sanders MD
Program Director
SCMS Trustee

Facebooktwittermail

2016 SCMS Photo Directory

The 2016 SCMS photo directory is almost complete. We will be mailing the directories out to you in early July. We will also be updating our electronic/online directory in July as well.

Thank you for updating your photos. If you notice any old or information that needs updating, please contact the SCMS office at: LMK@wsma.org or call: 206-956-3624

Facebooktwittermail

Health Alert From Snohomish Health District

Today’s topics:
•    Loperamide as opioid substitute
•    Fentanyl
•    Chronic pain training
•    Testing for Zika virus
•    Ticks

Loperamide as opioid substitute
Action requested:  Be aware that persons addicted to opioids may abuse loperamide to get high.

Background & Recommendations:
A recent article in the Annals of Emergency Medicine reported two deaths due to supratherapeutic use of the over the counter anti-diarrheal drug, loperamide.  Supratherapeutic doses of loperamide produce central nervous system opioid effects, leading some patients use loperamide to self-treat their opioid addiction.  However, supratherapeutic doses of loperamide can also cause ventricular dysrhythmias. Providers should be aware of potential loperamide abuse and its complications when caring for persons addicted to opioids.

Fentanyl
Action requested:  Be aware that persons addicted to opioids may be using street drugs containing fentanyl, for which much higher doses of naloxone are needed to reverse overdoses.

Background & Recommendations:
Pharmaceutical fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain. Prescribed as transdermal patches or lozenges, fentanyl is 50 to 100 times more potent than morphine and has increasingly been diverted for abuse in the United States.  However, most recent cases of fentanyl-related harm, overdose, and death in the U.S. are linked to illegally made fentanyl, often mixed with heroin and/or cocaine to increase the euphoric effects of those drugs.  As illegally made fentanyl confiscations have increased nationwide, so have fentanyl-related overdose deaths. Although fentanyl overdoses can be reversed with naloxone, providers should be aware that substantially higher doses or multiple doses of naloxone may be required.

For more information, click here.

Chronic Pain Training
Action requested:  Take advantage of free training about current recommendations for opioid management of chronic pain.

Background & Recommendations:
The Centers for Disease Control & Prevention (CDC) is offering a webinar/call presenting an overview of the recently released CDC guidelines. Learn when and how opioids should be initiated for chronic pain, how to assess risk and address harms of opioid use, and when and how opioids should be discontinued. This is the first in a series of four calls. Free continuing medical education credit is available. Registration is not required.  For details, click here.

Testing for Zika virus
Actions requested:  Include urine samples when testing for acute symptomatic Zika virus infection and be aware of guidance to properly interpret any Zika test results.

Background
Based on increased experience when testing for Zika virus, CDC has updated its guidance for clinicians.  Real-time reverse transcription–polymerase chain reaction (rRT-PCR) is the preferred test for acute symptomatic Zika virus infection. rRT-PCR can be performed rapidly and is highly specific. However, Zika virus RNA is unlikely to be detected in serum after the first week of illness.  Several studies have documented prolonged detection of Zika virus in urine, including a recent study by the Florida Department of Health comparing Zika virus PCR results in serum, urine, and saliva.  The study concluded that urine specimens are more likely than serum specimens to test positive for Zika virus among persons with confirmed or probable Zika virus disease and who had traveled to areas with endemic Zika virus (see Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease — Florida, 2016).  Consequently, CDC now recommends that rRT-PCR testing of urine should be performed in conjunction with serum testing.

Interpreting test results can be complicated.  A positive rRT-PCR result confirms Zika virus infection, but a negative rRT-PCR result does not exclude infection.

Immunoglobulin (Ig) M and neutralizing antibody testing may identify additional recent Zika virus infections among persons with negative rRT-PCR results, but cross-reactivity with other flaviviruses (e.g., dengue and West Nile) means the specific virus may not be identifiable.  In such situations, clinicians should test for both Zika and dengue.  (Note: For serum specimens collected <7 days after onset of symptoms, a negative rRT-PCR result and negative IgM antibody testing suggests that there was no recent infection.)  CDC specifically advises:

“Pregnant women with laboratory evidence of Zika virus infection should be evaluated and managed for possible adverse pregnancy outcomes and be reported to the U.S. Zika Pregnancy Registry or the Puerto Rico Zika Active Pregnancy Surveillance System for clinical follow-up.  All patients with clinically suspected dengue should have proper management to reduce the risk for hemorrhage and shock. If serologic testing indicates recent flavivirus infection that could be caused by either Zika or dengue virus, patients should be clinically managed for both infections because they might have been infected with either virus.”

Recommendations
1.    Continue to advise pregnant patients to avoid travel to areas where Zika virus transmission is ongoing because of the potential for microcephaly and other poor pregnancy outcomes in babies of mothers infected with Zika virus while pregnant.  Advise pregnant women who can’t postpone travel to an area with Zika virus transmission to strictly follow steps to avoid mosquito bites. Insect repellents containing DEET, picaridin, and IR3535 are considered safe for pregnant women when used as directed.  No specific antiviral treatment is available for Zika disease. Treatment is generally supportive and can include rest, fluids, and use of analgesics and antipyretics. Pregnant women who have a fever should be treated with acetaminophen.

2.    Collect serum for rRT-PCR testing from symptomatic patients with exposure to Zika virus who present within 7 days of illness onset.  Collect urine for Zika virus rRT-PCR testing on symptomatic patients with exposure to Zika virus who present within 14 days of illness onset.

3.    Collect serum for IgM antibody testing on symptomatic patients ≥4 days after symptom onset and asymptomatic pregnant patients 2-12 weeks following exposure.

4.    Contact the Health District at 425-339-5278 to determine eligibility for Zika virus testing and to arrange for testing.

5.    Be aware that the COPA America Centenario international soccer tournament is occurring in Seattle on June 4, June 14, and June 16.  Organizers anticipate a surge of international travelers, many from Zika-affected countries.  Consider the potential for Zika infections among tournament participants from other countries who present with Zika symptoms.

For more information about testing for Zika virus infection, see Interim Guidance for Zika Virus Testing of Urine — United States, 2016 and Interim Guidance for Interpretation of Zika Virus Antibody Test Results.

Tickborne diseases
Action requested:  Be aware of updated guidelines for the diagnosis and management of tickborne rickettsial diseases.

Background & Recommendations:
CDC has just issued a report “to assist health care providers and public health professionals to 1) recognize key epidemiologic features and clinical manifestations of tickborne rickettsial diseases, 2) recognize that doxycycline is the treatment of choice for suspected tickborne rickettsial diseases in adults and children, 3) understand that early empiric antibacterial therapy can prevent severe disease and death, 4) request the appropriate confirmatory diagnostic tests and understand their usefulness and limitations, and 5) report probable and confirmed cases of tickborne rickettsial diseases to public health authorities.”  Details can be found here.

You can find my recent health alerts posted on the Provider pages of our website.

Gary Goldbaum, MD, MPH 
Health Officer & Director
Administration

Facebooktwittermail